Visit Our Team
Meet the our team to learn how Hi-C on routine FFPE biopsies is redefining structural variant, enhancer-hijacking, and epigenetic dysregulation detection in lymphoid cancers, including events that standard panels often miss. Our experts can walk you through how FFPE-compatible Hi-C sensitively detects both common and rare enhancer-donating rearrangements, maps 3D chromatin features such as compartments, TADs, and loops, and links these structural changes to altered gene regulation in cancer.
Read more on our recent partnership with Fox Chase Cancer Center.